Stay updated on ALXN1210 vs Eculizumab in PNH Clinical Trial
Sign up to get notified when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.

Latest updates to the ALXN1210 vs Eculizumab in PNH Clinical Trial page
- Check5 days agoChange DetectedNo substantive changes to the study details or data were observed; only minor formatting/layout adjustments appear in the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a government funding lapse notice and current operating status guidance with a new v3.2.0 release; removed the old v3.1.0 tag.SummaryDifference3%

- Check41 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check55 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No substantive changes to core content, pricing, or availability.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check69 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, particularly in Europe and Asia, as well as the inclusion of new medical terms and references related to paroxysmal nocturnal hemoglobinuria.SummaryDifference17%

Stay in the know with updates to ALXN1210 vs Eculizumab in PNH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.